Peripartale Blutungen, Diagnostik und Therapie. Leitlinie der DGGG, OEGGG und SGGG (S2k, AWMF Registernummer 015-063, August 2022)

Zusammenfassung

Ziel Das Ziel dieser offiziellen Leitlinie, die von der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) publiziert und koordiniert wurde, ist es, durch die Evaluation der relevanten Literatur einen konsensbasierten Überblick über die Diagnostik und das Management der peripartalen Blutung zu geben.

Methoden Diese S2k-Leitlinie wurde durch einen strukturierten Konsens von repräsentativen Mitgliedern verschiedener Professionen im Auftrag des Leitlinienprogramms der DGGG, OEGGG und SGGG entwickelt.

Empfehlungen Es werden Empfehlungen zur Definition, Risikostratifizierung, Prävention, Therapie (allgemeine Notfallmaßnahmen, medikamentös, Uterustamponade, operative Maßnahmen, interventionell-radiologische Maßnahmen, Hämostase und Gerinnungsmanagement), Transport, Dokumentation und Nachbesprechung sowie Training gegeben. Zusätzlich wird ein PPH-Handlungsalgorithmus „PPH 2022“ empfohlen.

Schlüsselwörter

postpartale Hämorrhagie - postpartale Blutung - Placenta-accreta-Spektrum - PPH-Algorithmus - Uterotonika - Tranexamsäure - Tamponade - operative Maßnahmen - Kompressionsnähte - Embolisation - Hämostase und Gerinnungsmanagement - anästhesiologisches Management - maschinelle Autotransfusion

Publication History

Received: 06 April 2023

Accepted: 09 April 2023

Article published online:
28 June 2023

• References/Literatur

• 1 Sheldon WR, Blum J, Vogel JP. et al. Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 2014; 121 (Suppl. 01) 5-13
• 2 Reale SC, Easter SR, Xu X. et al. Trends in Postpartum Hemorrhage in the United States From 2010 to 2014. Anesth Analg 2020; 130: e119-e122
• 3 Greene RA, McKernan J, Manning E. et al. Major obstetric haemorrhage: Incidence, management and quality of care in Irish maternity units. Eur J Obstet Gynecol Reprod Biol 2021; 257: 114-120
• 4 Deneux-Tharaux C, Bonnet MP, Tort J. [Epidemiology of post-partum haemorrhage]. J Gynecol Obstet Biol Reprod (Paris) 2014; 43: 936-950
• 5 Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994–2006. Am J Obstet Gynecol 2010; 202: 353.e1-353.e6
• 6 Kramer MS, Berg C, Abenhaim H. et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol 2013; 209: 449.e1-449.e7
• 7 Joseph KS, Rouleau J, Kramer MS. et al. Investigation of an increase in postpartum haemorrhage in Canada. BJOG 2007; 114: 751-759
• 8 Samangaya R, Pennington R, Vause S. Factors relating to a rising incidence of major postpartum haemorrhage. BJOG 2010; 117: 370 author reply 370–371
• 9 Kramer MS, Dahhou M, Vallerand D. et al. Risk Factors for Postpartum Hemorrhage: Can We Explain the Recent Temporal Increase?. J Obstet Gynaecol Can 2011; 33: 810-819
• 10 Buchanan SL, Patterson JA, Roberts CL. et al. Trends and morbidity associated with oxytocin use in labour in nulliparas at term. Aust N Z J Obstet Gynaecol 2012; 52: 173-178
• 11 Mehrabadi A, Hutcheon JA, Lee L. et al. Epidemiological investigation of a temporal increase in atonic postpartum haemorrhage: a population-based retrospective cohort study. BJOG 2013; 120: 853-862
• 12 Mousa HA, Walkinshaw S. Major postpartum haemorrhage. Curr Opin Obstet Gynecol 2001; 13: 595-603
• 13 AbouZahr C. Global burden of maternal death and disability. Br Med Bull 2003; 67: 1-11
• 14 Khan KS, Wojdyla D, Say L. et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-1074
• 15 Roberts CL, Ford JB, Algert CS. et al. Trends in adverse maternal outcomes during childbirth: a population-based study of severe maternal morbidity. BMC Pregnancy Childbirth 2009; 9: 7
• 16 Haeri S, Dildy 3rd GA. Maternal mortality from hemorrhage. Semin Perinatol 2012; 36: 48-55
• 17 Grobman WA, Bailit JL, Rice MM. et al. Frequency of and factors associated with severe maternal morbidity. Obstet Gynecol 2014; 123: 804-810
• 18 Cantwell R, Clutton-Brock T, Cooper G. et al. Saving Mothersʼ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118 (Suppl. 01) 1-203
• 19 Bouvier-Colle MH, Saucedo M, Deneux-Tharaux C. CNEMM. [The confidential enquiries into maternal deaths, 1996–2006 in France: what consequences for the obstetrical care?]. J Gynecol Obstet Biol Reprod (Paris) 2011; 40: 87-102
• 20 Farquhar C, Sadler L, Masson V. et al. Beyond the numbers: classifying contributory factors and potentially avoidable maternal deaths in New Zealand, 2006–2009. Am J Obstet Gynecol 2011; 205: 331.e1-331.e8
• 21 Saucedo M, Deneux-Tharaux C, Bouvier-Colle MH. French National Experts Committee on Maternal Mortality. Ten years of confidential inquiries into maternal deaths in France, 1998–2007. Obstet Gynecol 2013; 122: 752-760
• 22 Duthie SJ, Ven D, Yung GLK. et al. Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery. Eur J Obstet Gynecol Reprod Biol 1991; 38: 119-124
• 23 Descargues G, Pitette P, Gravier A. et al. [Missed diagnosis of postpartum hemorrhage]. J Gynecol Obstet Biol Reprod (Paris) 2001; 30: 590-600
• 24 Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 2006; 113: 919-924
• 25 Rath W, Schneider M. Definitionen und Diagnostik postpartaler Blutungen (PPH): Unterschätzte Probleme!. Geburtshilfe Frauenheilkd 2010; 70: 36-40
• 26 Schlembach D, Annecke T, Girard T. et al. Peripartal haemorrhage, diagnosis and therapy. Guideline of the German Society of Gynaecology and Obstetrics (S2k-Level, AWMF Registry No. 015/063, June 2022). 2022 Accessed June 18, 2023 at: http://www.awmf.org/leitlinien/detail/ll/015-063.html
• 27 Bouwmeester FW, Bolte AC, van Geijn HP. Pharmacological and surgical therapy for primary postpartum hemorrhage. Curr Pharm Des 2005; 11: 759-773
• 28 Schlembach D, Mörtl MG. Postpartale Hämorrhagie – Von der Definition über die Klinik zur Diagnose. Speculum 2010; 28: 5-9
• 29 Borovac-Pinheiro A, Pacagnella RC, Cecatti JG. et al. Postpartum hemorrhage: new insights for definition and diagnosis. Am J Obstet Gynecol 2018; 219: 162-168
• 30 Drew T, Carvalho JCA, Subramanian C. et al. The association of shock index and haemoglobin variation with postpartum haemorrhage after vaginal delivery: a prospective cohort pilot study. Int J Obstet Anesth 2021; 45: 67-73
• 31 Merz E, Eichhorn KH, von Kaisenberg C. et al. Arbeitsgruppe der DEGUM-Stufe III. [Updated quality requirements regarding secondary differentiated ultrasound examination in prenatal diagnostics (= DEGUM level II) in the period from 18 + 0 to 21 + 6 weeks of gestation]. Ultraschall Med 2012; 33: 593-596
• 32 Main EK, Goffman D, Scavone BM. et al. National Partnership for Maternal Safety. Obstet Gynecol 2015; 126: 155-162
• 33 Dupont C, Touzet S, Colin C. et al. Incidence and management of postpartum haemorrhage following the dissemination of guidelines in a network of 16 maternity units in France. Int J Obstet Anesth 2009; 18: 320-327
• 34 Mavrides E, Allard S, Chandraharan E. et al. Prevention and Management of Postpartum Haemorrhage: Green-top Guideline No. 52. BJOG 2017; 124: e106-e149
• 35 Upadhyay K, Scholefield H. Risk management and medicolegal issues related to postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008; 22: 1149-1169
• 36 Driessen M, Bouvier-Colle MH, Dupont C. et al. Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity. Obstet Gynecol 2011; 117: 21-31
• 37 Abdul-Kadir R, McLintock C, Ducloy AS. et al. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion 2014; 54: 1756-1768
• 38 Dupont C, Deneux-Tharaux C, Touzet S. et al. Clinical audit: a useful tool for reducing severe postpartum haemorrhages?. Int J Qual Health Care 2011; 23: 583-589
• 39 Shields LE, Smalarz K, Reffigee L. et al. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products. Am J Obstet Gynecol 2011; 205: 368.e1-368.e8
• 40 Ananth CV, Smulian JC, Vintzileos AM. The association of placenta previa with history of cesarean delivery and abortion: a metaanalysis. Am J Obstet Gynecol 1997; 177: 1071-1078
• 41 Getahun D, Oyelese Y, Salihu HM. et al. Previous cesarean delivery and risks of placenta previa and placental abruption. Obstet Gynecol 2006; 107: 771-778
• 42 Marshall NE, Fu R, Guise JM. Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol 2011; 205: 262.e1-262.e8
• 43 Klar M, Michels KB. Cesarean section and placental disorders in subsequent pregnancies–a meta-analysis. J Perinat Med 2014; 42: 571-583
• 44 Downes KL, Hinkle SN, Sjaarda LA. et al. Previous prelabor or intrapartum cesarean delivery and risk of placenta previa. Am J Obstet Gynecol 2015; 212: 669.e1-669.e6
• 45 Grady R, Alavi N, Vale R. et al. Elective single embryo transfer and perinatal outcomes: a systematic review and meta-analysis. Fertil Steril 2012; 97: 324-331
• 46 Korosec S, Ban Frangez H, Verdenik I. et al. Singleton pregnancy outcomes after in vitro fertilization with fresh or frozen-thawed embryo transfer and incidence of placenta praevia. Biomed Res Int 2014; 2014: 431797
• 47 Qin J, Liu X, Sheng X. et al. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertil Steril 2016; 105: 73-85.e1–e6
• 48 Karami M, Jenabi E, Fereidooni B. The association of placenta previa and assisted reproductive techniques: a meta-analysis. J Matern Fetal Neonatal Med 2018; 31: 1940-1947
• 49 Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol 2005; 26: 89-96
• 50 Jauniaux E, Alfirevic Z, Bhide AG. et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. BJOG 2019; 126: e1-e48
• 51 Reddy UM, Abuhamad AZ, Levine D. et al. Fetal Imaging Workshop Invited Participants. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. J Ultrasound Med 2014; 33: 745-757
• 52 Ghi T, Contro E, Martina T. et al. Cervical length and risk of antepartum bleeding in women with complete placenta previa. Ultrasound Obstet Gynecol 2009; 33: 209-212
• 53 Zaitoun MM, El Behery MM, Abd El Hameed AA. et al. Does cervical length and the lower placental edge thickness measurement correlates with clinical outcome in cases of complete placenta previa?. Arch Gynecol Obstet 2011; 284: 867-873
• 54 Mimura T, Hasegawa J, Nakamura M. et al. Correlation between the cervical length and the amount of bleeding during cesarean section in placenta previa. J Obstet Gynaecol Res 2011; 37: 830-835
• 55 Sekiguchi A, Nakai A, Okuda N. et al. Consecutive cervical length measurements as a predictor of preterm cesarean section in complete placenta previa. J Clin Ultrasound 2015; 43: 17-22
• 56 Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005; 192: 1458-1461
• 57 Thurn L, Lindqvist PG, Jakobsson M. et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 2016; 123: 1348-1355
• 58 Silver RM, Landon MB, Rouse DJ. et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107: 1226-1232
• 59 Rajan PV, Wing DA. Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol 2010; 53: 165-181
• 60 Bailit JL, Grobman WA, Rice MM. et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol 2015; 125: 683-689
• 61 Bowman ZS, Eller AG, Kennedy AM. et al. Accuracy of ultrasound for the prediction of placenta accreta. Am J Obstet Gynecol 2014; 211: 177.e1-177.e7
• 62 Timor-Tritsch IE, Monteagudo A, Cali G. et al. Cesarean Scar Pregnancy: Diagnosis and Pathogenesis. Obstet Gynecol Clin North Am 2019; 46: 797-811
• 63 Singh D, Kaur L. When a cesarean section scar is more than an innocent bystander in a subsequent pregnancy: Ultrasound to the rescue. J Clin Ultrasound 2017; 45: 319-327
• 64 Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol 2017; 217: 27-36
• 65 Collins SL, Ashcroft A, Braun T. et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol 2016; 47: 271-275
• 66 Tremblay E, Therasse E, Thomassin-Naggara I. et al. Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation. Radiographics 2012; 32: 897-911
• 67 Thomsen HS, Stacul F, Bellin M-F. et al. ESUR Guidelines on Contrast Agents. European Society of Urogenital Radiology; 2018. Accessed June 18, 2023 at: https://www.esur.org/esur-guidelines-on-contrast-agents/
• 68 Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol 2017; 130: e210-e216
• 69 Chen S, Pang D, Li Y. et al. Serum miRNA biomarker discovery for placenta accreta spectrum. Placenta 2020; 101: 215-220
• 70 Jauniaux E, Bhide A, Kennedy A. et al. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet 2018; 140: 274-280
• 71 Leduc D, Senikas V, Lalonde AB. No. 235-Active Management of the Third Stage of Labour: Prevention and Treatment of Postpartum Hemorrhage. J Obstet Gynaecol Can 2018; 40: e841-e855
• 72 Rath W. [Active management of the third stage of labour (AMTSL) – the end of a 50 years-dogma?]. Z Geburtshilfe Neonatol 2013; 217: 173-176
• 73 Sheldon WR, Durocher J, Winikoff B. et al. How effective are the components of active management of the third stage of labor?. BMC Pregnancy Childbirth 2013; 13: 46
• 74 Begley CM, Gyte GM, Devane D. et al. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev 2015; (03) CD007412
• 75 Gizzo S, Patrelli TS, Gangi SD. et al. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review. Reprod Sci 2013; 20: 1011-1019
• 76 Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev 2013; (10) CD001808
• 77 Weeks A. The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?. BJOG 2015; 122: 202-210
• 78 Moertl MG, Friedrich S, Kraschl J. et al. Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial. BJOG 2011; 118: 1349-1356
• 79 van der Nelson H, OʼBrien S, Burnard S. et al. Intramuscular oxytocin versus Syntometrine((R)) versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: a randomised double-blinded clinical trial of effectiveness, side effects and quality of life. BJOG 2021; 128: 1236-1246
• 80 Drugs and Lactation Database (LactMed) [Internet] – Ergonovine. Bethesda (MD): National Library of Medicine (US); 2006. Accessed June 18, 2023 at: https://www.ncbi.nlm.nih.gov/books/NBK501332/ [Updated 2018 Oct 31]
• 81 Sentilhes L, Daniel V, Deneux-Tharaux C. TRAAP2 Study Group and the Groupe de Recherche en Obstétrique et Gynécologie (GROG). TRAAP2 – TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial – a study protocol. BMC Pregnancy Childbirth 2020; 20: 63
• 82 Sentilhes L, Winer N, Azria E. et al. Tranexamic Acid for the Prevention of Blood Loss after Vaginal Delivery. N Engl J Med 2018; 379: 731-742
• 83 Morales M, Ceysens G, Jastrow N. et al. Spontaneous delivery or manual removal of the placenta during caesarean section: a randomised controlled trial. BJOG 2004; 111: 908-912
• 84 Anorlu RI, Maholwana B, Hofmeyr GJ. Methods of delivering the placenta at caesarean section. Cochrane Database Syst Rev 2008; (03) CD004737
• 85 Phung LC, Farrington EK, Connolly M. et al. Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol 2021; 225: 250.e1-250.e38
• 86 Rath W. [Postpartum Haemorrhage (PPH): “too little is done too late”!]. Z Geburtshilfe Neonatol 2011; 215: 177-181
• 87 Meiser A, Casagranda O, Skipka G. et al. [Quantification of blood loss. How precise is visual estimation and what does its accuracy depend on?]. Anaesthesist 2001; 50: 13-20
• 88 Larsson C, Saltvedt S, Wiklund I. et al. Estimation of blood loss after cesarean section and vaginal delivery has low validity with a tendency to exaggeration. Acta Obstet Gynecol Scand 2006; 85: 1448-1452
• 89 Toledo P, McCarthy RJ, Hewlett BJ. et al. The accuracy of blood loss estimation after simulated vaginal delivery. Anesth Analg 2007; 105: 1736-1740 table of contents
• 90 von Heymann C, Kaufner L, Korber M. [Perioperative management and therapy of bleeding complications]. Anasthesiol Intensivmed Notfallmed Schmerzther 2014; 49: 196-204 quiz 205
• 91 Kozek-Langenecker SA, Ahmed AB, Afshari A. et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol 2017; 34: 332-395
• 92 Parry Smith WR, Papadopoulou A, Thomas E. et al. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev 2020; (11) CD012754
• 93 Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol 2017; 130: e168-e186
• 94 Bienstock JL, Eke AC, Hueppchen NA. Postpartum Hemorrhage. N Engl J Med 2021; 384: 1635-1645
• 95 Leng G, Sabatier N. Measuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers. J Neuroendocrinol 2016; 28
• 96 Schmitz T, Tararbit K, Dupont C. et al. Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. Obstet Gynecol 2011; 118 (2 Pt 1): 257-265
• 97 Langer B, Boudier E, Haberstich R. et al. Collège National des Gynécologues et Obstétriciens Français; Agence Nationale dʼAccréditation et dʼEvaluation en Santé. [Obstetrical management in the event of persistent or worsening postpartum hemorrhage despite initial measures]. J Gynecol Obstet Biol Reprod (Paris) 2004; 33 (8 Suppl.): 4S73-4S79
• 98 Hösli I, Büchel J. Stellenwert von Kontraktionsmitteln bei der postpartalen Hämorrhagie. Gynäkologe 2019; 52: 408-415
• 99 Munoz M, Stensballe J, Ducloy-Bouthors AS. et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus 2019; 17: 112-136
• 100 Della Corte L, Saccone G, Locci M. et al. Tranexamic acid for treatment of primary postpartum hemorrhage after vaginal delivery: a systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med 2020; 33: 869-874
• 101 Shakur H, Roberts I, Fawole B. et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017; 389: 2105-2116
• 102 Gayet-Ageron A, Prieto-Merino D, Ker K. et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet 2018; 391: 125-132
• 103 Chan LL, Lo TK, Lau WL. et al. Use of second-line therapies for management of massive primary postpartum hemorrhage. Int J Gynaecol Obstet 2013; 122: 238-243
• 104 Ibrahim M, Ziegler C, Klam SL. et al. Incidence, indications, and predictors of adverse outcomes of postpartum hysterectomies: 20-year experience in a tertiary care centre. J Obstet Gynaecol Can 2014; 36: 14-20
• 105 Fox KA, Berghella V, Chakrabarti A. Postpartum hemorrhage: Use of intrauterine tamponade to control bleeding [updated September 26, 2022]. Accessed June 18, 2023 at: https://www.uptodate.com
• 106 Gronvall M, Tikkanen M, Tallberg E. et al. Use of Bakri balloon tamponade in the treatment of postpartum hemorrhage: a series of 50 cases from a tertiary teaching hospital. Acta Obstet Gynecol Scand 2013; 92: 433-438
• 107 Maier RC. Control of postpartum hemorrhage with uterine packing. Am J Obstet Gynecol 1993; 169 (2 Pt 1): 317-321 discussion 321 -323
• 108 Dabelea V, Schultze PM, McDuffie jr. RS. Intrauterine balloon tamponade in the management of postpartum hemorrhage. Am J Perinatol 2007; 24: 359-364
• 109 Patacchiola F, DʼAlfonso A, Di Fonso A. et al. Intrauterine balloon tamponade as management of postpartum haemorrhage and prevention of haemorrhage related to low-lying placenta. Clin Exp Obstet Gynecol 2012; 39: 498-499
• 110 Aibar L, Aguilar MT, Puertas A. et al. Bakri balloon for the management of postpartum hemorrhage. Acta Obstet Gynecol Scand 2013; 92: 465-467
• 111 Florian A, Carles G, Dallah F. et al. [Value of the Linton-Nachlas balloon for the management of post-partum hemorrhage: a series of 25 cases]. J Gynecol Obstet Biol Reprod (Paris) 2013; 42: 493-498
• 112 Nelson BD, Stoklosa H, Ahn R. et al. Use of uterine balloon tamponade for control of postpartum hemorrhage by community-based health providers in South Sudan. Int J Gynaecol Obstet 2013; 122: 27-32
• 113 Tindell K, Garfinkel R, Abu-Haydar E. et al. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG 2013; 120: 5-14
• 114 Morel O, Perdriolle-Galet E, Mezan de Malartic C. et al. [Management of severe or persistent postpartum hemorrhage after vaginal delivery]. J Gynecol Obstet Biol Reprod (Paris) 2014; 43: 1019-1029
• 115 Rodriguez MI, Bullard M, Jensen JT. et al. Management of Postpartum Hemorrhage With a Mini-Sponge Tamponade Device. Obstet Gynecol 2020; 136: 876-881
• 116 Schmid BC, Rezniczek GA, Rolf N. et al. Uterine packing with chitosan-covered gauze for control of postpartum hemorrhage. Am J Obstet Gynecol 2013; 209: 225.e1-225.e5
• 117 Carles G, Dabiri C, McHirgui A. et al. Uses of chitosan for treating different forms of serious obstetrics hemorrhages. J Gynecol Obstet Hum Reprod 2017; 46: 693-695
• 118 Dueckelmann AM, Hinkson L, Nonnenmacher A. et al. Uterine packing with chitosan-covered gauze compared to balloon tamponade for managing postpartum hemorrhage. Eur J Obstet Gynecol Reprod Biol 2019; 240: 151-155
• 119 Al-Harbi NA, Al-Abra ES, Alabbad NS. Utero-vaginal packing. Seven years review in the management of post partum hemorrhage due to placenta previa/accreta at a maternity hospital in Central Saudi Arabia. Saudi Med J 2009; 30: 243-246
• 120 Samartha Ram H, Shankar Ram HS, Panicker V. et al. Vacuum retraction of uterus for the management of atonic postpartum hemorrhage. IOSR J Dent Med Sci (IOSR-JDMS) 2014; 13: 15-19
• 121 Marasinghe JP. Control of Postpartum Hemorrhage Using Vacuum-Induced Uterine Tamponade. Obstet Gynecol 2016; 128: 910
• 122 Purwosunu Y, Sarkoen W, Arulkumaran S. et al. Control of Postpartum Hemorrhage Using Vacuum-Induced Uterine Tamponade. Obstet Gynecol 2016; 128: 33-36
• 123 Sentilhes L, Brun S, Madar H. et al. Control of Postpartum Hemorrhage Using Vacuum-Induced Uterine Tamponade. Obstet Gynecol 2016; 128: 909-910
• 124 DʼAlton ME, Rood KM, Smid MC. et al. Intrauterine Vacuum-Induced Hemorrhage-Control Device for Rapid Treatment of Postpartum Hemorrhage. Obstet Gynecol 2020; 136: 882-891
• 125 Hofmeyr GJ, Singata-Madliki M. Novel suction tube uterine tamponade for treating intractable postpartum haemorrhage: description of technique and report of three cases. BJOG 2020; 127: 1280-1283
• 126 Haslinger C, Weber K, Zimmermann R. Vacuum-Induced Tamponade for Treatment of Postpartum Hemorrhage. Obstet Gynecol 2021; 138: 361-365
• 127 Diemert A, Ortmeyer G, Hollwitz B. et al. The combination of intrauterine balloon tamponade and the B-Lynch procedure for the treatment of severe postpartum hemorrhage. Am J Obstet Gynecol 2012; 206: 65.e1-65.e4
• 128 Yoong W, Ridout A, Memtsa M. et al. Application of uterine compression suture in association with intrauterine balloon tamponade (‘uterine sandwich’) for postpartum hemorrhage. Acta Obstet Gynecol Scand 2012; 91: 147-151
• 129 Dhillon AS, Dhillon K. Use of combination method (uterine sandwich technique) to control postpartum hemorrhage. Int J Reprod Contracept Obstet Gynecol 2018; 7: 2753-2758
• 130 Seidel V, Braun T, Weizsacker K. et al. Application of chitosan-covered gauze in combination with intrauterine balloon tamponade for postpartum hemorrhage treatment – Case report of a novel “uterine sandwich” approach. Int J Surg Case Rep 2018; 48: 101-103
• 131 Nelson WL, OʼBrien JM. The uterine sandwich for persistent uterine atony: combining the B-Lynch compression suture and an intrauterine Bakri balloon. Am J Obstet Gynecol 2007; 196: e9-e10
• 132 Merrick K, Jibodu OA, Rajesh U. The difficult PPH: experience of combined use of B-Lynch brace suture and intrauterine Bakri balloon in York hospital, UK. J Obstet Gynaecol 2013; 33: 314-315
• 133 Cekmez Y, Ozkaya E, Ocal FD. et al. Experience with different techniques for the management of postpartum hemorrhage due to uterine atony: compression sutures, artery ligation and Bakri balloon. Ir J Med Sci 2015; 184: 399-402
• 134 Schlembach D, Mörtl MG, Girard T. et al. Management der postpartalen Blutung. Der D-A-CH-Algorithmus. Frauenarzt 2013; 54: 1072-1080
• 135 Carvajal JA, Ramos I, Kusanovic JP. et al. Damage-control resuscitation in obstetrics. J Matern Fetal Neonatal Med 2022; 35: 785-798
• 136 Deux JF, Bazot M, Le Blanche AF. et al. Is selective embolization of uterine arteries a safe alternative to hysterectomy in patients with postpartum hemorrhage?. AJR Am J Roentgenol 2001; 177: 145-149
• 137 Rath W, Hackethal A, Bohlmann MK. Second-line treatment of postpartum haemorrhage (PPH). Arch Gynecol Obstet 2012; 286: 549-561
• 138 Keogh J, Tsokos N. Aortic compression in massive postpartum haemorrhage–an old but lifesaving technique. Aust N Z J Obstet Gynaecol 1997; 37: 237-238
• 139 Riley DP, Burgess RW. External abdominal aortic compression: a study of a resuscitation manoeuvre for postpartum haemorrhage. Anaesth Intensive Care 1994; 22: 571-575
• 140 Pacheco LD, Lozada MJ, Saade GR. et al. Damage-Control Surgery for Obstetric Hemorrhage. Obstet Gynecol 2018; 132: 423-427
• 141 Yoong W, Lavina A, Ali A. et al. Abdomino-pelvic packing revisited: An often forgotten technique for managing intractable venous obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2019; 59: 201-207
• 142 Kainer F. Damage Control Surgery: Operative Behandlungskonzepte im Sinne einer „Life Saving Strategy“ – Uteruserhaltende Methoden im Gegensatz zur PP-Hysterektomie: Sind Organerhalt oder Reduktion von Morbidität und Mortalität ein Widerspruch?. Speculum 2010; 28: 22-24
• 143 Hollatz-Galuschki E, Michaelis S, Rauber S. et al. Uteruskompressionsnähte – Welche Nahttechnik ist wann indiziert?. Geburtshilfe Frauenheilkd 2013; 73: P70
• 144 AbdRabbo SA. Stepwise uterine devascularization: a novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus. Am J Obstet Gynecol 1994; 171: 694-700
• 145 Morel O, Malartic C, Muhlstein J. et al. Pelvic arterial ligations for severe post-partum hemorrhage. Indications and techniques. J Visc Surg 2011; 148: e95-e102
• 146 Ahonen J, Stefanovic V, Lassila R. Management of post-partum haemorrhage. Acta Anaesthesiol Scand 2010; 54: 1164-1178
• 147 Rossi AC, Lee RH, Chmait RH. Emergency postpartum hysterectomy for uncontrolled postpartum bleeding: a systematic review. Obstet Gynecol 2010; 115: 637-644
• 148 Schols SE, Feijge MA, Lance MD. et al. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets. Transfusion 2008; 48: 2384-2394
• 149 Tanaka KA, Key NS, Levy JH. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg 2009; 108: 1433-1446
• 150 Lier H, Hofer S, Annecke T. Anästhesiologisches Management der peripartalen Hämorrhagie. Anasthesiol Intensivmed Notfallmed Schmerzther 2020; 55: 686-701
• 151 Gillissen A, van den Akker T, Caram-Deelder C. et al. Association between fluid management and dilutional coagulopathy in severe postpartum haemorrhage: a nationwide retrospective cohort study. BMC Pregnancy Childbirth 2018; 18: 398
• 152 Futier E, Robin E, Jabaudon M. et al. Central venous O₂ saturation and venous-to-arterial CO₂ difference as complementary tools for goal-directed therapy during high-risk surgery. Crit Care 2010; 14: R193
• 153 Karlsson O, Jeppsson A, Hellgren M. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both?. Int J Obstet Anesth 2014; 23: 10-17
• 154 Mellin-Olsen J, Staender S, Whitaker DK. et al. The Helsinki Declaration on Patient Safety in Anaesthesiology. Eur J Anaesthesiol 2010; 27: 592-597
• 155 Grottke O, Frietsch T, Maas M. et al. German Society of Anaesthesiology and Intensive Care Medicine. [Dealing with massive bleeding and associated perioperative coagulopathy: recommendations for action of the German Society of Anaesthesiology and Intensive Care Medicine]. Anaesthesist 2013; 62: 213-216 218–220, 222–224
• 156 Einerson BD, Miller ES, Grobman WA. Does a postpartum hemorrhage patient safety program result in sustained changes in management and outcomes?. Am J Obstet Gynecol 2015; 212: 140-144.e1
• 157 Haslinger C, Korte W, Hothorn T. et al. The impact of prepartum factor XIII activity on postpartum blood loss. J Thromb Haemost 2020; 18: 1310-1319
• 158 Listyo S, Forrest E, Graf L. et al. The Need for Red Cell Support During Non-Cardiac Surgery Is Associated to Pre-Transfusion Levels of FXIII and the Platelet Count. J Clin Med 2020; 9: 2456
• 159 Wissenschaftlicher Beirat der Bundesärztekammer, Arbeitskreis „Querschnitts-Leitlinien Hämotherapie“. Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten – Gesamtnovelle 2020. Bundesärztekammer, Hrsg. 2020; Accessed June 18, 2023 at: https://www.bundesaerztekammer.de/fileadmin/user_upload/_old-files/downloads/pdf-Ordner/MuE/Querschnitts-Leitlinien_BAEK_zur_Therapie_mit_Blutkomponenten_und_Plasmaderivaten-Gesamtnovelle_2020.pdf Dt Ärzteblatt 2020; 117: A1883/B1603
• 160 Collins PW, Cannings-John R, Bruynseels D. et al. Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial. Br J Anaesth 2017; 119: 411-421
• 161 Collins PW, Lilley G, Bruynseels D. et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood 2014; 124: 1727-1736
• 162 Collins PW, Bell SF, de Lloyd L. et al. Management of postpartum haemorrhage: from research into practice, a narrative review of the literature and the Cardiff experience. Int J Obstet Anesth 2019; 37: 106-117
• 163 Lier H, Rath W. Aktuelle interdisziplinäre Handlungsempfehlungen bei schweren peri-(post-)partalen Blutungen (PPH). Geburtshilfe Frauenheilkd 2011; 71: 577-588
• 164 Alfirevic Z, Elbourne D, Pavord S. et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000–2004. Obstet Gynecol 2007; 110: 1270-1278
• 165 Barillari G, Frigo MG, Casarotto M. et al. Use of recombinant activated factor VII in severe post-partum haemorrhage: data from the Italian Registry: a multicentric observational retrospective study. Thromb Res 2009; 124: e41-e47
• 166 Phillips LE, McLintock C, Pollock W. et al. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg 2009; 109: 1908-1915
• 167 Huber AW, Raio L, Alberio L. et al. Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. J Perinat Med 2011; 40: 43-49
• 168 Lavigne-Lissalde G, Aya AG, Mercier FJ. et al. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. J Thromb Haemost 2015; 13: 520-529
• 169 Colucci G, Helsing K, Biasiutti FD. et al. Standardized Management Protocol in Severe Postpartum Hemorrhage: A Single-Center Study. Clin Appl Thromb Hemost 2018; 24: 884-893
• 170 European Medicines Agency (EMA) – Committee for Medicinal Products for Human Use (CHMP). CHMP extension of indication variation assessment report: NovoSeven (Procedure No. EMEA/H/C/000074/II/0116). Accessed June 18, 2023 at: https://www.ema.europa.eu/en/documents/variation-report/novoseven-h-c-000074-ii-0116-epar-assessment-report-variation_en.pdf
• 171 Karanth L, Barua A, Kanagasabai S. et al. Desmopressin acetate (DDAVP) for preventing and treating acute bleeds during pregnancy in women with congenital bleeding disorders. Cochrane Database Syst Rev 2019; (02) CD009824
• 172 Trigg DE, Stergiotou I, Peitsidis P. et al. A systematic review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. Haemophilia 2012; 18: 25-33
• 173 Kevane B, Donnelly J, DʼAlton M. et al. Risk factors for pregnancy-associated venous thromboembolism: a review. J Perinat Med 2014; 42: 417-425
• 174 Szecsi PB, Jorgensen M, Klajnbard A. et al. Haemostatic reference intervals in pregnancy. Thromb Haemost 2010; 103: 718-727
• 175 Karlsson O, Sporrong T, Hillarp A. et al. Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy. Anesth Analg 2012; 115: 890-898
• 176 James AH, Konkle BA, Bauer KA. Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency. Int J Womens Health 2013; 5: 233-241
• 177 Gallos G, Redai I, Smiley RM. The role of the anesthesiologist in management of obstetric hemorrhage. Semin Perinatol 2009; 33: 116-123
• 178 Kuczkowski KM. Anesthesia for the repeat cesarean section in the parturient with abnormal placentation: what does an obstetrician need to know?. Arch Gynecol Obstet 2006; 273: 319-321
• 179 Fuller AJ, Bucklin BA. Blood product replacement for postpartum hemorrhage. Clin Obstet Gynecol 2010; 53: 196-208
• 180 Bonnet MP, Deneux-Tharaux C, Bouvier-Colle MH. Critical care and transfusion management in maternal deaths from postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2011; 158: 183-188
• 181 Breymann C, Honegger C, Hösli I. et al. Diagnostik und Therapie der Eisenmangelanämie in der Schwangerschaft und postpartal. Expertenbrief Nr. 48 der Gynécologie Suisse SGGG (Kommission Qualitätssicherung). Gynäkologie 2017; 2: 31-34
• 182 Liu Y, Li X, Che X. et al. Intraoperative cell salvage for obstetrics: a prospective randomized controlled clinical trial. BMC Pregnancy Childbirth 2020; 20: 452
• 183 Khan KS, Moore P, Wilson M. et al. A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial. Health Technol Assess 2018; 22: 1-88
• 184 Sullivan IJ, Ralph CJ. Obstetric intra-operative cell salvage: a review of an established cell salvage service with 1170 re-infused cases. Anaesthesia 2019; 74: 976-983
• 185 Catling S, Haynes SL. Coagulopathy during intraoperative cell salvage in a patient with major obstetric haemorrhage. Br J Anaesth 2011; 106: 749 author reply 750
• 186 Waldron S. Hypotension associated with leucocyte depletion filters following cell salvage in obstetrics. Anaesthesia 2011; 66: 133-134
• 187 de Lange NM, van Rheenen-Flach LE, Lance MD. et al. Peri-partum reference ranges for ROTEM(R) thromboelastometry. Br J Anaesth 2014; 112: 852-859
• 188 Agarwal S, Laycock HC. The debate ROTEMs on – the utility of point-of-care testing and fibrinogen concentrate in postpartum haemorrhage. Anaesthesia 2020; 75: 1247-1251
• 189 Wikkelso AJ, Edwards HM, Afshari A. et al. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth 2015; 114: 623-633
• 190 Allen L, Jauniaux E, Hobson S. et al. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet 2018; 140: 281-290
• 191 Sentilhes L, Kayem G, Chandraharan E. et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet 2018; 140: 291-298
• 192 Collins SL, Alemdar B, van Beekhuizen HJ. et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol 2019; 220: 511-526
• 193 Teixidor Vinas M, Chandraharan E, Moneta MV. et al. The role of interventional radiology in reducing haemorrhage and hysterectomy following caesarean section for morbidly adherent placenta. Clin Radiol 2014; 69: e345-e351
• 194 Teixidor Vinas M, Belli AM, Arulkumaran S. et al. Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the Triple-P procedure. Ultrasound Obstet Gynecol 2015; 46: 350-355
• 195 Hsieh TT, Lee JD. Sonographic findings in acute puerperal uterine inversion. J Clin Ultrasound 1991; 19: 306-309
• 196 Pauleta JR, Rodrigues R, Melo MA. et al. Ultrasonographic diagnosis of incomplete uterine inversion. Ultrasound Obstet Gynecol 2010; 36: 260-261
• 197 Beringer RM, Patteril M. Puerperal uterine inversion and shock. Br J Anaesth 2004; 92: 439-441
• 198 You WB, Zahn CM. Postpartum hemorrhage: abnormally adherent placenta, uterine inversion, and puerperal hematomas. Clin Obstet Gynecol 2006; 49: 184-197
• 199 Witteveen T, van Stralen G, Zwart J. et al. Puerperal uterine inversion in the Netherlands: a nationwide cohort study. Acta Obstet Gynecol Scand 2013; 92: 334-337
• 200 Wilson AK, Martel MJ, Arsenault MY. et al. Maternal transport policy. J Obstet Gynaecol Can 2005; 27: 956-963
• 201 Wallwiener D, Beckmann MW. 219. Stellungnahme. Stellungnahme zur Frage der postoperativen Überwachung von Kaiserschnittpatientinnen. Geburtshilfe Frauenheilkd 2015; 75: 1216-1218
• 202 Gude P, Weber T. Geburtshilfliche Anästhesie und postoperative Überwachung. Practice Guidelines for Obstetric Anesthesia (ASA Task Force und SOAP) und Stellungnahme der DGAI/BDA zur postoperativen Überwachung nach Sectio. Anasthesiol Intensivmed Notfallmed Schmerzther 2018; 53: 696-702
• 203 Artyomenko VV, Nosenko VM. Anaesthesiologistsʼ simulation training during emergencies in obstetrics. Rom J Anaesth Intensive Care 2017; 24: 37-40
• 204 Buljac-Samardzic M, Doekhie KD, van Wijngaarden JDH. Interventions to improve team effectiveness within health care: a systematic review of the past decade. Hum Resour Health 2020; 18: 2
• 205 Armenia S, Thangamathesvaran L, Caine AD. et al. The Role of High-Fidelity Team-Based Simulation in Acute Care Settings: A Systematic Review. Surg J (N Y) 2018; 4: e136-e151